Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for December 21st

Read MoreHide Full Article

Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 21st:

Mallinckrodt plc (MNKKQ - Free Report) : This developer and manufacturer of specialty pharmaceutical products and therapies has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 13.7% over the last 60 days.

Mallinckrodt public limited company Price and Consensus

Mallinckrodt has a price-to-earnings ratio (P/E) of 0.06 compared with 0.20 for the industry. The company possesses a Value Score of A.

Mallinckrodt public limited company PE Ratio (TTM)

Danaos Corporation (DAC - Free Report) : This owner and operator of containerships in Australia, Asia, Europe, and the United States has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 1.6% over the last 60 days.

Danaos Corporation Price and Consensus

Danaos has a price-to-earnings ratio (P/E) of 2.85 compared with 9.70 for the industry. The company possesses a Value Score of A.

Danaos Corporation PE Ratio (TTM)

Elevate Credit, Inc. (ELVT - Free Report) : This provider of online credit solutions to non-prime consumers in the United States and the United Kingdom has Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 25% over the last 60 days.

Elevate Credit, Inc. Price and Consensus

Elevate Credit has a price-to-earnings ratio (P/E) of 3.04 compared with 12.90 for the industry. The company possesses a Value Score of A.

Elevate Credit, Inc. PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Danaos Corporation (DAC) - free report >>

Elevate Credit, Inc. (ELVT) - free report >>

Mallinckrodt public limited company (MNKKQ) - free report >>